UAE Insulin Delivery Devices Market to grow with a CAGR of 8.25%
Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Insulin Delivery Devices Market.
According to TechSci Research report, “UAE
Insulin Delivery Devices Market Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Insulin Delivery Devices Market has
valued at USD 0.28 billion in 2022 and is anticipated to witness an impressive
growth in the forecast period with a CAGR of 8.25% through 2028. This can be due to collaborations and
partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market.
A patient-centric approach is a
significant driver for the demand of insulin delivery devices. Insulin delivery
devices designed with a focus on the user experience, such as simple
interfaces, ergonomic designs, and easy-to-use features, are more likely to be
embraced by patients. This can drive demand as patients seek devices that fit
seamlessly into their daily lives. Patient-centric insulin delivery devices
often aim to minimize needle anxiety. Features such as smaller and finer
needles, as well as innovations like needle-free options, contribute to a more
comfortable and positive experience for users. Insulin delivery devices that offer dosing flexibility and
adaptability to individual patients’ needs contribute to a personalized
treatment experience. Patients appreciate devices that allow them to tailor
their insulin administration to their unique lifestyle and health requirements.
A patient-centric approach involves
providing comprehensive education and support programs. Patients who are
well-informed about the benefits and usage of insulin delivery devices are more
likely to incorporate them into their diabetes management routine. Insulin
delivery devices that integrate with digital platforms, such as smartphone
apps, enable patients to monitor and manage their diabetes more effectively.
This connectivity enhances the overall patient experience and drives demand for
technologically advanced solutions.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Insulin Delivery Devices Market.”
In February 2023, EOFlow
Co., Ltd. has announced that its partner in the Gulf Cooperation Council (GCC),
GulfDrug LLC (Gulf Drug) based in the United Arab Emirates (UAE), has
officially launched the EOPatch, a tubeless, wearable, and disposable insulin
pump, in the UAE. The EOPatch stands out as one of only two fully disposable,
wearable insulin pump solutions available commercially worldwide. The EOPatch Insulin
Management System, featuring a tubeless, wearable, and disposable 'Patch'
insulin pump along with a dedicated controller known as ADM or a smartphone app
called Narsha, is designed for continuous insulin delivery to aid in blood
glucose control. This innovative solution offers an alternative to traditional
insulin delivery methods. The patch, with its user-friendly and wearable
design, delivers continuous insulin for up to three and a half days (84 hours),
allowing for a twice-a-week replacement cycle, ultimately enhancing user
compliance.
Cultural
and behavioral factors pose challenges in the UAE Insulin Delivery Devices
Market. Cultural factors may influence individuals to prefer
traditional or alternative medicine over modern medical interventions,
including insulin therapy. Overcoming these cultural preferences can be a
challenge for the adoption of insulin delivery devices. In some
cultures, there may be a stigma associated with diabetes or chronic diseases.
This stigma can impact individuals' willingness to openly discuss and seek
treatment for diabetes, including the use of insulin delivery devices. Cultural
attitudes towards needles and injections can influence individuals' acceptance
of insulin delivery devices. Needle phobia may be more prevalent in certain
cultural contexts, leading to resistance to using devices that involve
injections. Family and community dynamics play a significant role in
decision-making in many cultures. The acceptance or rejection of insulin
delivery devices may be influenced by the opinions and preferences of family
members and the broader community.
UAE Insulin Delivery
Devices Market is segmented based on Product Type, Distribution Channel, End
User, and by region.
Based on the Product Type,
UAE Insulin Delivery Devices Market is segmented into Pens, Pumps, Pen Needles.
Insulin pumps are small
electronic devices designed to deliver a continuous and precise supply of
insulin to individuals with diabetes. They aim to mimic the function of the
pancreas by providing a continuous background (basal) insulin infusion and
allowing users to administer additional doses (bolus) when needed, such as
before meals. Insulin
pumps allow for precise and customizable insulin delivery, enabling users to
closely match their insulin requirements to their daily activities and
physiological needs. Users have the flexibility to adjust basal rates
and administer bolus doses, providing a personalized approach to diabetes
management. This flexibility is particularly beneficial for individuals with
variable insulin needs.
Based on Region, Abu Dhabi region held the largest share
in the UAE Insulin Delivery Devices Market.
There are research and development
centers or institutions focused on diabetes management and medical device
innovation in Abu Dhabi, it could contribute to the region's dominance in the
insulin delivery devices market. Higher awareness and education about diabetes
and the benefits of insulin delivery devices among healthcare professionals and
the general population in Abu Dhabi may lead to increased adoption of these
devices. Population density, age demographics, and the prevalence of diabetes
in the Abu Dhabi region may be factors contributing to a higher demand for
insulin delivery devices.
Some of the major companies operating in
the UAE Insulin
Delivery Devices Market include:
- Abbott
Laboratories, S.A.
- Roche
Diabetes Care Middle East
- Julphar
Pharmaceuticals
- Medtronic
Meta FZ-LLC
- Novoordisk
Pharma Gulf FZ- LLC
Download free Sample Report
Customers
can also request 10% free customization on this report.
“Certain areas,
particularly in Dubai, are projected to exert significant demand for Insulin
Delivery Devices. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the UAE Insulin Delivery Devices Market in the forecast period,"
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Global management consulting firm.
UAE Insulin Delivery
Devices Market by Product Type (Pens {Disposable, Reusable}, Pumps
{External/Tethered Pumps, Patch Pumps}, Pen Needles {Standard Pen Needles,
Safety Pen Needles), Others) By Distribution Channel (Hospital Pharmacies,
Retail Pharmacies, Online, Others) By End User (Hospitals & Clinics,
Homecare, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE
Insulin Delivery Devices Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
innovative market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in UAE Insulin
Delivery Devices Market.
Contact
Mr. Ken
Mathews
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com